Cargando…
Sustained high expression of Fcγ receptorII (CD32) on dendritic cells (DCs) in patients with rheumatoid arthritis (RA)
Autores principales: | Radstake, TRDJ, Blom, A, van Gorselen, E, Engelen, L, Adema, G, van Lent, P, Barrera, P, Figdor, C, van den Berg, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273133/ http://dx.doi.org/10.1186/ar485 |
Ejemplares similares
-
Triggering of FcGR during dendritic cell maturation leads to a decreased expression of the chemokines DC-CK1, ELC and TARC
por: Radstake, TRDJ, et al.
Publicado: (2004) -
Increased FcγRII and III expression in synovium and on monocyte derived macrophages of RA-patients results in altered function after immune complex stimulation
por: Blom, AB, et al.
Publicado: (2002) -
Increased expression of chemokines DC-CK1, ELC and TARC by dendritic cells and in synovium from patients with rheumatoid arthritis
por: Radstake, T, et al.
Publicado: (2004) -
The inhibitory receptor FcγRII reduces joint inflammation in immune complex arthritis not only by inhibition of activatory FcγR but also by efficient clearance of immune complexes
por: van Lent, PL, et al.
Publicado: (2003) -
Activating FcγRIII determines cartilage destruction during immune complex arthritis but not in the presence of T-cell immunity
por: van Lent, PLEM, et al.
Publicado: (2002)